Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Supratherapeutic anticoagulation from low-molecular-weight heparin in lung transplant recipients.

Singer JP, Huang MY, Hui C, Blanc PD, Boettger RF, Golden J, Watkins K, Hoopes C, Leard LE.

J Heart Lung Transplant. 2010 Sep;29(9):1009-13. doi: 10.1016/j.healun.2010.04.018.

2.

Low molecular weight heparin dosing and monitoring in solid organ transplant recipients.

Moten MA, Gaber AO, Putney D, Patel SJ.

Clin Transplant. 2013 Nov-Dec;27(6):852-7. doi: 10.1111/ctr.12240.

PMID:
24033530
3.

Evaluation of Enoxaparin Dosing as a Risk Factor for Bleeding in Lung Transplant Recipients.

Sofjan AK, Iuppa JA, Bain KB, Deal EN, Witt CA, Hachem RR, Yusen RD.

Ann Pharmacother. 2016 Oct;50(10):824-31. doi: 10.1177/1060028016656434.

PMID:
27363845
4.

Enoxaparin dose adjustment is associated with low incidence of venous thromboembolic events in acute burn patients.

Lin H, Faraklas I, Saffle J, Cochran A.

J Trauma. 2011 Dec;71(6):1557-61. doi: 10.1097/TA.0b013e31823070f9.

PMID:
22027887
5.
6.

Enoxaparin dosing in the elderly using adjusted body weight.

Leri F, Voyce SJ, Scialla S, Glavich W, Dzielak E, Smego RA Jr, Guzek J.

J Thromb Thrombolysis. 2009 Oct;28(3):348-53. doi: 10.1007/s11239-009-0320-8.

PMID:
19283449
7.

Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients.

Droege ME, Mueller EW, Besl KM, Lemmink JA, Kramer EA, Athota KP, Droege CA, Ernst NE, Keegan SP, Lutomski DM, Hanseman DJ, Robinson BR.

J Trauma Acute Care Surg. 2014 Feb;76(2):450-6. doi: 10.1097/TA.0000000000000087.

PMID:
24458050
8.

Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin.

Rowan BO, Kuhl DA, Lee MD, Tichansky DS, Madan AK.

Obes Surg. 2008 Feb;18(2):162-6. doi: 10.1007/s11695-007-9381-y.

PMID:
18165884
9.

Prospective Evaluation of Weight-Based Prophylactic Enoxaparin Dosing in Critically Ill Trauma Patients: Adequacy of AntiXa Levels Is Improved.

Nunez JM, Becher RD, Rebo GJ, Farrah JP, Borgerding EM, Stirparo JJ, Lauer C, Kilgo P, Miller PR.

Am Surg. 2015 Jun;81(6):605-9.

PMID:
26031274
10.

Non-therapeutic anti-Xa levels in medical patients receiving anticoagulant therapy with enoxaparin.

Ramos-Esquivel A, Salazar-Sánchez L.

Thromb Res. 2013 Oct;132(4):433-6. doi: 10.1016/j.thromres.2013.08.017.

PMID:
24050826
11.

Anti-Xa activity after enoxaparin prophylaxis in hospitalized patients weighing less than fifty-five kilograms.

Rojas L, Aizman A, Ernst D, Acuña MP, Moya P, Mellado R, Cerda J.

Thromb Res. 2013;132(6):761-4. doi: 10.1016/j.thromres.2013.10.005.

PMID:
24521789
12.

Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency.

Lim W, Dentali F, Eikelboom JW, Crowther MA.

Ann Intern Med. 2006 May 2;144(9):673-84.

PMID:
16670137
13.

Alternative dosing of prophylactic enoxaparin in the trauma patient: is more the answer?

Kopelman TR, O'Neill PJ, Pieri PG, Salomone JP, Hall ST, Quan A, Wells JR, Pressman MS.

Am J Surg. 2013 Dec;206(6):911-5; discussion 915-6. doi: 10.1016/j.amjsurg.2013.10.005.

PMID:
24296098
14.

Standard prophylactic enoxaparin dosing leads to inadequate anti-Xa levels and increased deep venous thrombosis rates in critically ill trauma and surgical patients.

Malinoski D, Jafari F, Ewing T, Ardary C, Conniff H, Baje M, Kong A, Lekawa ME, Dolich MO, Cinat ME, Barrios C, Hoyt DB.

J Trauma. 2010 Apr;68(4):874-80. doi: 10.1097/TA.0b013e3181d32271.

PMID:
20386282
16.
17.

Fixed-dose enoxaparin after bariatric surgery: the influence of body weight on peak anti-Xa levels.

Celik F, Huitema AD, Hooijberg JH, van de Laar AW, Brandjes DP, Gerdes VE.

Obes Surg. 2015 Apr;25(4):628-34. doi: 10.1007/s11695-014-1435-3.

PMID:
25223871
18.

Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma.

Ko A, Harada MY, Barmparas G, Chung K, Mason R, Yim DA, Dhillon N, Margulies DR, Gewertz BL, Ley EJ.

JAMA Surg. 2016 Nov 1;151(11):1006-1013. doi: 10.1001/jamasurg.2016.1662.

PMID:
27383732
19.

Variability of plasma anti-Xa activities with different lots of enoxaparin.

Gosselin RC, King JH, Janatpour KA, Dager WE, Larkin EC, Owings JT.

Ann Pharmacother. 2004 Apr;38(4):563-8.

PMID:
14982983
20.

Comparison of two low-molecular-weight heparin dosing regimens for patients undergoing laparoscopic bariatric surgery.

Simone EP, Madan AK, Tichansky DS, Kuhl DA, Lee MD.

Surg Endosc. 2008 Nov;22(11):2392-5. doi: 10.1007/s00464-008-9997-6.

PMID:
18594915
Items per page

Supplemental Content

Support Center